User profiles for Giovanni Matera

Matera Giovanni

University Catanzaro
Verified email at unicz.it
Cited by 2375

Inhibition of Toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis

…, MF Roelofs, TRDJ Radstake, G Matera… - … : Official Journal of …, 2007 - Wiley Online Library
Objective Degeneration of extracellular matrix of cartilage leads to the production of molecules
capable of activating the immune system via Toll‐like receptor 4 (TLR‐4). The objective of …

[HTML][HTML] Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility

…, E Lio, G Procopio, FS Costanzo, DP Foti, G Matera… - Scientific reports, 2020 - nature.com
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world and many COVID-19 outbreaks have been reported in long-term care …

[HTML][HTML] Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study

B Grazioli, G Matera, C Laratta, G Schipani… - World journal of …, 2006 - ncbi.nlm.nih.gov
AIM: To evaluate the prevalence of Giardia lamblia (G. lamblia) infection in patients with irritable
bowel syndrome (IBS) and dyspepsia and to establish which is the most accurate test to …

[HTML][HTML] Efficacy of cefiderocol-vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant …

…, R Serraino, F Romeo, N Marascio, G Matera… - International journal of …, 2023 - Elsevier
Introduction Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) in patients hospitalized in intensive care units (ICUs) is an …

Bartonella quintana Lipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4

…, N Takahashi, T Sprong, G Matera… - Infection and …, 2007 - Am Soc Microbiol
Bartonella quintana is a gram-negative microorganism that causes trench fever and chronic
bacteremia. B. quintana lipopolysaccharide (LPS) was unable to induce the production of …

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae …

…, M Mazzitelli, N Marascio, G Matera… - Journal of …, 2019 - academic.oup.com
Sir, Cefiderocol is a new siderophore cephalosporin, with potent activity against MDR Gram-negative
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …

[PDF][PDF] Six cases of sepsis caused by Pantoea agglomerans in a teaching hospital.

MC Liberto, G Matera, R Puccio… - The new …, 2009 - newmicrobiologica.org
Pantoea agglomerans is an environmental organism which may seldom cause opportunistic
infections. Here we report on a 6 case outbreak in a teaching hospital. Within three months …

[HTML][HTML] Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia

…, D Lagana, FS Costanzo, G Matera… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, Di Giambenedetto et al. 1 described their experience with intravenous tocilizumab
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …

Receptor Recognition of and Immune Intracellular Pathways for Veillonella parvula Lipopolysaccharide

G Matera, V Muto, M Vinci, E Zicca… - Clinical and vaccine …, 2009 - Am Soc Microbiol
Veillonella parvula is an anaerobic gram-negative coccus that is part of the normal flora of
the animal and human mouth and gastrointestinal and genitourinary tracts. Oral V. parvula is …

[HTML][HTML] SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections

…, A Russo, EM Trecarichi, G Matera… - Clinical Chemistry and …, 2023 - degruyter.com
Objectives Nearly three years into the pandemic, SARS-CoV-2 infections are occurring in
vaccinated and naturally infected populations. While humoral and cellular responses in COVID-…